Publicacions
-
Moser LM, Hutter M, Ahlmann M, Alonso-Saladrigues A, Attarbaschi A, Ayuk FA, Baldus CD, Balduzzi A, Bonig H, Bourquin JP, Buechner J, Buecklein VL, Burridge S, Calkoen FG, Cario G, De Moerloose B, de Oliveira Canedo G, Dourthe ME, Feuchtinger T, Füreder A, Hauer J, Ifversen M, Jarisch A, Kalwak K, Klusmann JH, Kobbe G, Koenecke C, Künkele A, Meisel R, Merli P, Mielcarek-Siedziuk M, Müller F, Müller I, Napolitano S, Espuelas MO, Penack O, Rabian F, Rossig C, Sauer MG, Schlegel PG, von Stackelberg A, Strahm B, Willier S, Bader P, Rives-Solà S, Boissel N, Locatelli F, Ghorashian S and Baruchel A.
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.
LEUKEMIA . : .
